Intrinsic Value of S&P & Nasdaq Contact Us

Predictive Oncology Inc. POAI NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
29/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Predictive Oncology Inc. (POAI) reported total assets of $52.89M and total liabilities of $5.17M for quarter ending 2025-12-31, resulting in total equity of $47.72M.

The company held $10.79M in cash and short-term investments. Total debt stood at $1.56M, with net debt of $-9.23M. The Debt-to-Equity (D/E) ratio was 0.03 (conservative).

Current ratio is 10.02, indicating strong short-term liquidity.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — Debt-to-Equity of 0.03, current ratio of 10.02 — balance sheet is strong
  • MOAT (28/100) — Total assets $52.89M and equity $47.72M support the company's competitive scale

Overall SharesGrow Score: 28/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
28/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Predictive Oncology Inc. Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $52.89M$3.14M$3.44M$5.87M
Total Liabilities $5.17M$80.57M$5.09M$6.01M
Total Debt $1.56M$1.89M$2.11M$1.92M
Cash & Investments $10.79M$181.67K$506.08K$3.09M
Total Stockholders Equity $47.72M$-77.43M$-1.65M$-145.8K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message